Adial Pharmaceuticals, Inc. Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current
Adial Pharmaceuticals, Inc. (ADIL) had Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current of $58.50 thousand as of 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes › Discontinued Operations and Disposal Groups › Disposal Group, Including Discontinued Operation, Liabilities, Current
us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent · last filed 2025-03-04
- 2024-12-31: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current $58.50K.
- 2023-12-31: Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current $58.50K.
| Period end | Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current |
|---|---|
| 2024-12-31 | $58.50K 10-K · filed 2025-03-04 |
| 2023-12-31 | $58.50K 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |